L-680833

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameL-680833
Drug Alias NameL-680833
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukocyte elastase inhibitors
TargetsLeukocyte elastase
Therapy Area/IndicationsEmphysemaBlood Coagulation DisordersArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsEmphysemaBlood Coagulation DisordersArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A